Biotechnology

Alpha Compute

ALP.US released FY2026 Q2 earnings on January 13, 2026 (BJT) with actual revenue of USD 0 and EPS of USD -4.1343

Alpha Compute released FY2025 Q2 earnings on January 13, 2026 (EST) with actual revenue of USD 0 and EPS of USD -1.2639

Alpha Compute released FY2026 Q1 earnings on January 13 (EST), actual revenue USD 0, actual EPS USD -2.566

Alpha Compute released FY2025 Semi-Annual earnings on January 13, 2026 (EST), with actual revenue of USD 0 and EPS of USD -2.8372

Alpha Compute released FY2026 Semi-Annual Earnings on January 13 (EST), actual revenue USD 0, actual EPS USD -5.1321

ALP.US released FY2024 Annual Earnings on July 25 (BJT), actual revenue USD 0, actual EPS USD -77.83

Alpha Compute released FY2025 Q3 earnings on July 25, 2025 (EST), with actual revenue of USD 0 and EPS of USD -1.4393

Alpha Compute released FY2023 Annual Earnings on July 25, 2025 (EST) with actual revenue of USD 0 and EPS of USD -129.7903

Alpha Compute released FY2025 Annual Earnings on July 25 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -5.7202 (forecast USD --)

ALP.US released FY2025 Q4 earnings on July 25, 2025 (BJT) with actual revenue of USD 0 and EPS of USD -1.4393

< 1B

1B - 5B

5B - 10B

10B - 50B

50B - 100B

100B - 500B

500B - 1T

≥ 1T

Market Value

Total Assets

< 100M

100M - 500M

500M - 1B

≥ 100B

Revenue

0 - 50M

50M - 100M

≥ 10B

Profits

< 0%

0% - 5%

5% - 10%

10 - 15%

15% - 20%

20 - 25%

25% - 30%

>= 30%

ROE(TTM)

= 0%

0% - 1%

1% - 3%

3% - 5%

5% - 8%

8% - 10%

>= 10%

Dividend Yield

0% - 10%

10% - 15%

20% - 30%

30% - 40%

40% - 50%

>= 50%

Net Profit Margin

0 - 0.05

0.05 - 0.1

0.1 - 0.2

0.2 - 0.4

0.4 - 0.6

0.6 - 0.8

0.8 - 1

>= 1

Asset Turnover

< 1.5

1.5 - 2

2 - 3

3 - 5

5 - 10

10 - 15

15 - 20

>= 20

Equity Multiplier

< 10%

10% - 30%

30% - 50%

50% - 70%

70 - 80%

80% - 90%

90% - 95%

>= 95%

Debt Ratio

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Wellgistics Health

Huachen AI Parking Management Tech

GeoVax Labs

Sunshine Biopharma

AIM ImmunoTech

Virax Biolabs

NextNRG

GCT Semiconductor

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

QUCY

STAA

WGRX

DOCS

IPHA

MDXH

In Thursday's pre-market session, several health care stocks experienced significant movements. Alpha Compute (ALP) surged 71.3% to $0.46, while Innate Pharma (IPHA) rose 24.24% to $1.64. Quantum Cyber (QUCY) increased by 23.88% to $1.66, and Staar Surgical (STAA) gained 21.32% to $35.67. Conversely, MDxHealth (MDXH) fell 41.0% to $1.15, and WORK Medical Tech (WOK) dropped 27.9% to $1.99. Other notable losers included Doximity (DOCS) down 23.43% to $17.91 and Wellgistics Health (WGRX) down 17.53% to $0.08. Earnings reports influenced these movements.

benzinga_article

Quantum Cyber NV

STAAR Surgical

WORK Medical Tech

Doximity

Innate Pharma SA

MDxHealth SA

GT Biopharma

Cormedix

Regenxbio

Mainz Biomed NV

SUNSHINE BIOPHARMA INC C/WTS (TO PUR COM)

12 Health Care Stocks Moving In Thursday's Pre-Market Session

NVDA

Alpha Compute Corp. has secured a $32.2 million contract with a leading AI research lab for a two-year compute agreement involving 504 NVIDIA B200 GPUs in Canada. This deal will generate $16.1 million in annual recurring revenue and includes a $7.5 million upfront payment. The partnership highlights Alpha Compute's commitment to providing specialized AI infrastructure and marks a significant milestone in its commercial strategy. The company aims to expand its sales pipeline for dedicated GPU infrastructure to meet growing demand from AI research organizations and enterprises.

- Alpha Compute Corp. has signed a two-year lease agreement valued at $32.2 million with a leading AI research lab for 504 NVIDIA B200 GPUs in Canada.  
- This agreement generates $16.1 million in annual recurring revenue and includes a $7.5 million upfront payment for reserving compute capacity.  
- The partnership signifies Alpha Compute's strategic expansion into the AI infrastructure market, reflecting strong demand for high-performance GPU resources.

StockTitan

NVIDIA

Alpha Compute Closes $32.2 Million Revenue Contract with AI Lab Customer | ALP Stock News

Alpha Compute Corp. Provides GAMEE Acquisition Update; Closing Expected in May 2026 Pending Completion of GAMEE’s 2025 Financial Audit | ALP Stock News

Alpha Compute Corp. Provides GAMEE Acquisition Update; Closing Expected in May 2026 Pending Completion of GAMEE’s 2025 Financial Audit | ALP Stock News

REPL

CPIX

In Thursday's trading session, several health care stocks experienced significant movements. EUDA Health Holdings surged 127.5% to $13.74, while Cumberland Pharma rose 23.6% to $3.77. Other gainers included NewcelX (+22.4%), Replimune Group (+18.72%), cbdMD (+16.66%), and Citius Pharmaceuticals (+15.94%). Conversely, SILO Pharma dropped 25.4% to $0.43, Medpace Holdings fell 22.98% to $391.63, and Alpha Compute decreased 21.48% to $0.18. Other notable losers included Icecure Medical, Altimmune, and Axe Compute.

Ownership	%Owned	Share Chg	Report Date
Sabby Management, LLC	8.84%	No Change	31/03/2026
Orca Capital GmbH	2.73%	No Change	28/01/2026
Compedica Holdings, Ltd	2.67%	No Change	21/07/2025
Shay Capital LLC	2.61%	No Change	31/03/2026
Gregory H. Bailey	2.13%	No Change	21/07/2025
James Mellon	1.15%	No Change	21/07/2025
FNY Investment Advisers, LLC	0.76%	No Change	31/03/2026
One68 Global Capital, LLC	0.48%	No Change	31/03/2026
Prelude Capital Management, LLC	0.36%	No Change	31/03/2026
Armistice Capital LLC	0.24%	No Change	30/09/2024

Alpha Compute(ALP.US)

Valuation analysis

Institutional View & Shareholder

Analyst Ratings

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Alpha Compute Closes $32.2 Million Revenue Contract with AI Lab Customer | ALP Stock News

Alpha Compute Corp. Provides GAMEE Acquisition Update; Closing Expected in May 2026 Pending Completion of GAMEE’s 2025 Financial Audit | ALP Stock News

12 Health Care Stocks Moving In Thursday's Intraday Session